State of Florida to use untried cocktail in execution of Mark Asay
A UK biotech start-up has gained a sought after ‘promising innovative medicine’ (PIM) designation for its ultra-rare disease gene therapy.
Creating patient personas from large data sets can drive greater understanding of patients’ behaviours.
Is it time for Apple vs Google in healthcare?
Behavioural science can be applied to inform and improve outcomes all round.
Status of immunotherapies in non-small cell lung cancer (NSCLC).
mHealth, AI and IoT have all been hyped, but what is their potential long-term value to healthcare?
19/09/2017August 21, 2017
06/09/2017August 2, 2017
20/06/2017June 1, 2017
‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.